MF
IOVA icon

Magnetar Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Magnetar Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9K Buy
+13,448
New +$51.1K ﹤0.01% 1099
2025
Q1 		– Sell
-14,623
Closed -$108K – 836
2024
Q4 		$108K Buy
+14,623
New +$136K ﹤0.01% 575
2024
Q3 		– Sell
-82,363
Closed -$661K – 609
2024
Q2 		$661K Buy
+82,363
New +$883K 0.01% 310
2021
Q1 		– Sell
-9,004
Closed -$418K – 1121
2020
Q4 		$418K Buy
+9,004
New +$357K 0.01% 585

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Magnetar Financial's IOVA Position: Q2 2026 in Review

Magnetar Financial opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 13,448 shares worth $55.9K. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in IOVA as recently as Q4 2024.

Magnetar Financial first reported a position in IOVA in Q4 2020 and has held it in 4 quarters since. The position peaked at $661K in Q2 2024. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Magnetar Financial held 13,448 shares of Iovance Biotherapeutics worth $55.9K as of Q2 2026.
  • Iovance Biotherapeutics was a new Magnetar Financial position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #1099 holding.
  • Magnetar Financial first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 4 quarters since.
  • Magnetar Financial's Iovance Biotherapeutics position peaked at $661K in Q2 2024.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.